Literature DB >> 18158356

Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats.

Fredrik Palm1, Stephanie G Connors, Margarida Mendonca, William J Welch, Christopher S Wilcox.   

Abstract

Angiotensin-converting enzyme inhibitors (ACEIs) decrease the glomerular filtration rate and renal blood flow in the clipped kidneys of early 2-kidney, 1-clip Goldblatt hypertensive rats, but the consequences for oxygenation are unclear. We investigated the hypothesis that angiotensin II type 1 or angiotensin II type 2 receptors or NO synthase mediate renal oxygenation responses to ACEI. Three weeks after left renal artery clipping, kidney function, oxygen (O(2)) use, renal blood flow, renal cortical blood flow, and renal cortical oxygen tension (Po(2)) were measured after acute administration of an ACEI (enalaprilat) and after acute administration of ACEI following acute administration of an angiotensin II type 1 or angiotensin II type 2 receptor blocker (candesartan or PD-123,319) or an NO synthase blocker (N(G)-nitro-L-arginine methyl ester with control of renal perfusion pressure) and compared with mechanical reduction in renal perfusion pressure to the levels after ACEI. The basal renal cortical Po(2) of clipped kidneys was significantly lower than contralateral kidneys (35+/-1 versus 51+/-1 mm Hg; n=40 each). ACEI lowered renal venous Po(2), cortical Po(2), renal blood flow, glomerular filtration rate, and cortical blood flow and increased the renal vascular resistance in the clipped kidney, whereas mechanical reduction in renal perfusion pressure was ineffective. PD-123,319 and N(G)-nitro-L-arginine methyl ester, but not candesartan, reduced the Po(2) of clipped kidneys and blocked the fall in Po(2) with acute ACEI administration. In conclusion, oxygen availability in the clipped kidney is maintained by angiotensin II generation, angiotensin II type 2 receptors, and NO synthase. This discloses a novel mechanism whereby angiotensin can prevent hypoxia in a kidney challenged with a reduced perfusion pressure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158356     DOI: 10.1161/HYPERTENSIONAHA.107.097832

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

Review 1.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

Review 2.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

3.  Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis.

Authors:  Monika L Gloviczki; James F Glockner; Lilach O Lerman; Michael A McKusick; Sanjay Misra; Joseph P Grande; Stephen C Textor
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

Review 4.  Blood oxygen level-dependent (BOLD) MRI in renovascular hypertension.

Authors:  Monika L Gloviczki; Lilach O Lerman; Stephen C Textor
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

5.  Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease.

Authors:  Monika L Gloviczki; James Glockner; Sabas I Gomez; Juan C Romero; Lilach O Lerman; Michael McKusick; Stephen C Textor
Journal:  Invest Radiol       Date:  2009-09       Impact factor: 6.016

Review 6.  VEGF therapy for the kidney: emerging strategies.

Authors:  Erika Guise; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2018-02-14

Review 7.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

8.  Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep.

Authors:  Stephen A Contag; Jianli Bi; Mark C Chappell; James C Rose
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-13

Review 9.  The angiotensin II type 2 receptor: what is its clinical significance?

Authors:  Ivonne Hernandez Schulman; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

Review 10.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.